2025 ICD-10-CM code F19.282
Dependence on a psychoactive substance not classified elsewhere, accompanied by a sleep disorder induced by the substance.
Medical necessity for interventions related to this code is established by the documented presence of a substance dependence disorder causing significant impairment in function, alongside a clinically significant sleep disorder attributed to the substance use.Documentation should clearly link the sleep disorder to the substance use.
Providers diagnose the condition based on medical history, signs and symptoms, a detailed inquiry into personal and social behaviors, and a physical examination. Laboratory tests of blood, urine, other bodily fluids, and hair may be done to check levels of psychoactive substances and metabolites. Treatment approaches include cognitive behavioral therapy, psychotherapy, residential treatment, and group therapy.
- 6 (Mental, Behavioral and Neurodevelopmental disorders)
- F19.2 (Other psychoactive substance dependence)
In simple words: This diagnosis means a person is unable to quit using a drug that's affecting their sleep.It's used when doctors either don't know what specific drug is causing the problem or if the person is using multiple drugs at the same time.
Other psychoactive substance dependence with psychoactive substance-induced sleep disorder refers to the inability to stop using a psychoactive substance, where the substance taken has caused a sleep disorder. This code is used when the specific substance isn't identified by another code, or when there's combined (polysubstance) or nonselective (indiscriminate) drug use documented.
Example 1: A patient presents with insomnia, anxiety, and difficulty concentrating. They admit to regular use of multiple unidentified substances.The sleep disturbance is attributed to the substance use. F19.282 is used due to the combined substance use., A patient struggling with insomnia and vivid nightmares is diagnosed with dependence on a designer drug not otherwise specified in the ICD-10-CM.F19.282 is applied as the sleep disorder is directly linked to the substance dependence., A patient with a history of polysubstance abuse reports excessive daytime sleepiness and difficulty maintaining sleep. They exhibit drug-seeking behaviors. Upon examination and lab testing, they're diagnosed with substance dependence with a sleep disorder. F19.282 is used due to the dependence and induced sleep disorder.
Documentation should include: type of substance use (if known), signs and symptoms of dependence, details of the sleep disturbance, evidence of impaired function due to substance use, and results of any laboratory testing.
- Specialties:Addiction Medicine, Psychiatry, Psychology
- Place of Service:Inpatient Hospital, Outpatient Hospital, Office, Residential Substance Abuse Treatment Facility,Non-residential Substance Abuse Treatment Facility,Non-residential Opioid Treatment Facility, Community Mental Health Center, Inpatient Psychiatric Facility, Psychiatric Facility-Partial Hospitalization